Soleno Therapeutics Income Statement (2013-2025) | SLNO

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Dec2016	Mar2017	Jun2017	Sep2017	Dec2017	Mar2018	Jun2018	Sep2018	Dec2018	Mar2019	Jun2019	Sep2019	Dec2019	Mar2020	Jun2020	Sep2020	Mar2025	Jun2025	Sep2025	Dec2025
Revenue & cost
Revenue (Quarter)		0.27M	0.00M														-1.36M	32.66M	66.02M	91.73M
Cost of Revenue (Quarter)		0.03M																0.70M	1.14M	0.86M
Gross Profit (Quarter)	0.06M	0.06M	-0.04M															31.96M	64.88M	90.87M
Operating items
Research & Development (Quarter)	0.29M	0.33M	0.77M	0.95M	1.02M	1.18M	1.71M	2.09M	2.19M	2.76M	3.75M	4.49M	5.27M	6.70M	6.10M	4.83M	13.52M	9.15M	8.40M	9.56M
Selling, General & Administrative (Quarter)	1.54M	1.02M	2.19M	1.69M	1.68M	1.87M	1.77M	1.56M	1.36M	2.01M	1.70M	1.61M	1.61M	2.00M	2.25M	2.26M	29.26M	28.24M	33.75M	40.88M
Other Operating Expenses (Quarter)	251.00	-0.00M		0.01M	0.00M	0.00M	0.00M			0.21M	0.18M	0.03M	-0.13M	0.58M	2.84M	0.77M	2.97M	1.80M	1.75M	1.72M
Operating Expenses (Quarter)	1.83M	1.37M	2.97M	2.63M	5.20M	3.48M	3.41M	3.88M	3.54M	4.98M	5.62M	6.13M	6.75M	9.28M	11.19M	7.86M	45.74M	39.18M	43.91M	52.15M
Operating Income (Quarter)	4.20M	-1.37M	-2.97M	-2.63M	2.31M	-3.48M	-3.41M	-3.88M	-3.54M	-4.98M	-5.62M	-6.13M	-6.75M	-9.28M	-11.19M	-7.86M	-45.74M	-6.53M	22.11M	39.58M
EBIT (Quarter)	4.20M	-1.37M	-2.97M	-2.63M	2.31M	-3.48M	-3.41M	-3.88M	-3.54M	-4.98M	-5.62M	-6.13M	-6.75M	-9.28M	-11.19M	-7.86M	-45.74M	-6.53M	22.11M	39.58M
Non-operating items
Interest & Investment Income (Quarter)		0.00M	0.00M	0.00M													3.33M	3.19M	5.30M	5.13M
Other Non Operating Income (Quarter)	0.41M	-0.67M	-0.09M	0.00M	0.01M	0.02M	0.03M	0.03M	0.03M	0.06M	0.05M	0.03M	0.02M	0.01M	0.00M	0.00M
Non Operating Income (Quarter)	0.41M	-0.67M	-0.09M	0.14M	0.01M	0.02M	0.03M	1.57M	2.38M	0.06M	-4.38M	0.03M	-7.42M	0.01M	0.00M	-0.69M	1.97M	1.82M	3.91M	3.78M
Net income details
EBT (Quarter)	4.20M	-1.37M	-2.96M	-2.63M	2.31M	-3.48M	-3.41M	-3.88M	-3.54M	-4.98M	-5.62M	-6.13M	-6.75M	-9.28M	-11.19M	-7.86M	-43.77M	-4.71M	26.01M	43.36M
Profit After Tax (Quarter)	-6.75M	-2.04M	-3.97M	-3.79M	-1.15M	-3.80M	-7.06M	-2.74M	0.39M	-7.03M	-10.01M	0.89M	-14.62M	-5.86M	-7.38M	-8.54M	-43.77M	-4.71M	26.01M	43.37M
Net Income - Minority (Quarter)
Income from Continuing Operations (Quarter)	4.20M	-1.37M	-2.96M	-2.63M	2.31M	-3.48M	-3.41M	-3.88M	-3.54M	-4.98M	-5.62M	-6.13M	-6.75M	-9.28M	-11.19M	-7.86M	-43.77M	-4.71M	26.01M	43.36M
Consolidated Net Income (Quarter)	4.14M	-0.84M	-0.91M	-1.09M	-3.19M	-0.51M	-0.42M	-0.43M	-0.13M					-9.28M	-11.19M	-7.86M	-43.77M	-4.71M	26.01M	43.36M
Income towards Parent Company (Quarter)	4.14M	-0.84M	-0.91M	-1.09M	-3.19M	-0.51M	-0.42M	-0.43M	-0.13M					-9.28M	-11.19M	-7.86M	-43.77M	-4.71M	26.01M	43.36M
Preferred Dividend Payments (Quarter)	172.00
Net Income towards Common Stockholders (Quarter)	-2.61M	-0.84M	-0.91M	-1.09M	-3.19M	-0.51M	-0.42M	-0.43M	-0.13M					-9.28M	-11.19M	-7.86M	-43.77M	-4.71M	26.01M	43.36M
Additional items
EPS (Basic) (Quarter)	-1.99	-0.57	-0.42	-0.26	-0.77	-0.19	-0.35	-0.13	0.11	-0.22	-0.31	0.03	-0.39	-0.13	-0.16	-0.11	-0.95	-0.09	0.49	0.85
EPS (Weighted Average and Diluted) (Quarter)								-0.13				-0.19				-0.11	-0.95	-0.09	0.47	0.84
Shares Outstanding (Weighted Average) (Quarter)	0.49M	0.59M	2.43M	8.11M	8.98M	19.53M	20.35M	21.43M	0.51M	6.02M	31.78M	31.79M	0.12M	44.68M	6.02M	79.58M	46.18M	50.48M	50.02M	50.82M
Shares Outstanding (Diluted Average) (Quarter)																	46.18M	48.34M		52.38M
EBITDA (Quarter)	4.20M	-1.37M	-2.97M	-2.63M	2.31M	-3.48M	-3.41M	-3.88M	-3.54M	-4.98M	-5.62M	-6.13M	-6.75M	-9.28M	-11.19M	-7.86M	-43.91M	-4.85M	26.29M	43.41M
Interest Expenses (Quarter)																	1.36M	1.38M	1.39M	1.35M

Research Tools

Soleno Therapeutics Income Statement (2013-2025) | SLNO

Create an account

Sign In

Reset Password